Juan Feng

36 Sanhao Street
Shenyang, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 100 publications

Retraction notice to "Exosome-transported lncRNA H19 induces blood-brain barrier disruption in cerebral ischemic stroke via the H19/microRNA-18a/VEGF axis" [NSC 500 (2022) 41-51].

Retraction notice to "Exosome-transported lncRNA H19 induces blood-brain barrier disruption in cerebral ischemic stroke via the H19/microRNA-18a/VEGF axis" [NSC 500 (2022) 41-51].

Journal: Neuroscience
Published: April 10, 2026

The NLRP3 inflammasome as a dynamic context-dependent regulator: mechanisms, disease progression, and therapeutic implications.

The NLRP3 inflammasome as a dynamic context-dependent regulator: mechanisms, disease progression, and therapeutic implications.

Journal: Journal of translational medicine
Published: April 04, 2026

Author Correction: Alternate-day fasting ameliorates α-synuclein pathology and suppresses inflammation via the gut-brain axis in an MPTP-induced subacute mouse model of Parkinson's disease.

Author Correction: Alternate-day fasting ameliorates α-synuclein pathology and suppresses inflammation via the gut-brain axis in an MPTP-induced subacute mouse model of Parkinson's disease.

Journal: NPJ biofilms and microbiomes
Published: February 10, 2026

Rethinking Neuroregenerative Microenvironments: Synergy Between Bioengineering and Organoids.

Rethinking Neuroregenerative Microenvironments: Synergy Between Bioengineering and Organoids.

Journal: Advanced healthcare materials
Published: January 26, 2026

Upregulated GBP2 exacerbates Parkinson's disease pathogenesis by impairing NIX-dependent mitophagy.

Upregulated GBP2 exacerbates Parkinson's disease pathogenesis by impairing NIX-dependent mitophagy.

Journal: Redox biology
Published: December 28, 2025

Obinutuzumab β for aquaporin-4-positive neuromyelitis optica spectrum disorder: a phase 3 randomized controlled trial.

Obinutuzumab β for aquaporin-4-positive neuromyelitis optica spectrum disorder: a phase 3 randomized controlled trial.

Journal: Nature medicine
Published: December 19, 2025

Impact of hospital process reengineering on door-to-needle time for intravenous thrombolysis in acute ischemic stroke (PROMISE-CHINA): a multicenter prospective pre-post quasi-experimental study.

Impact of hospital process reengineering on door-to-needle time for intravenous thrombolysis in acute ischemic stroke (PROMISE-CHINA): a multicenter prospective pre-post quasi-experimental study.

Journal: Frontiers in neurology
Published: November 17, 2025

From mechanisms to therapies: the multifaceted roles of guanylate-binding protein 2 in immunity, cancer, and beyond.

From mechanisms to therapies: the multifaceted roles of guanylate-binding protein 2 in immunity, cancer, and beyond.

Journal: Frontiers in immunology
Published: September 18, 2025

Efficacy and Safety of Adjunctive Cenobamate in Chinese Participants with Focal Seizure.

Efficacy and Safety of Adjunctive Cenobamate in Chinese Participants with Focal Seizure.

Journal: Advances in therapy
Published: September 12, 2025

Immune cells in cerebral small vessel disease: Emerging roles and potential targeting therapies.

Immune cells in cerebral small vessel disease: Emerging roles and potential targeting therapies.

Journal: Neural regeneration research
Published: June 24, 2025

Reciprocal association between dietary diversity and subjective well-being in Chinese older adults: a three-wave longitudinal study.

Reciprocal association between dietary diversity and subjective well-being in Chinese older adults: a three-wave longitudinal study.

Journal: Archives of public health = Archives belges de sante publique
Published: May 23, 2025

Therapeutic strategies targeting complement in myasthenia gravis patients.

Therapeutic strategies targeting complement in myasthenia gravis patients.

Journal: Journal of neurology
Published: May 11, 2025
Showing 1-12 of 100

Last Updated: 09/26/2026